What is Clarium?
Clarium is a specialized healthcare technology firm dedicated to revolutionizing the hospital supply chain. Founded in 2020 by Steve Liou, the company addresses the critical inefficiencies that plague medical procurement and inventory management. At the heart of its offering is Astra OS, an AI-powered platform that synthesizes fragmented data into actionable insights and intelligent workflow automation. By providing a unified view of the supply chain, Clarium enables major health systems—including Stanford, Yale New Haven Health, and Geisinger—to reduce operational friction and improve resource allocation. The company occupies a vital niche at the intersection of enterprise software and clinical operations, positioning itself as an essential partner for modern health systems striving for operational excellence.
How much funding has Clarium raised?
Clarium has raised a total of $37.5M across 2 funding rounds:
Other Financing Round
$10.5M
Series A
$27M
Other Financing Round (2024): $10.5M with participation from Yale New Haven Health, General Catalyst, and Kaiser Permanente Ventures
Series A (2025): $27M led by Kaiser Permanente, Texas Medical Center, AlleyCorp companies, 1984 Ventures, and General Catalyst
Key Investors in Clarium
General Catalyst
General Catalyst is a prominent venture capital firm that partners with founders to build enduring enterprises, leveraging deep sector expertise to accelerate growth across healthcare and enterprise software.
Kaiser Permanente
Kaiser Permanente is a leading not-for-profit healthcare provider that integrates medical services with health insurance, focusing on technological innovation to improve patient outcomes.
Texas Medical Center
Texas Medical Center is a premier medical community in Houston that fosters cross-institutional collaboration and life science research to drive advancements in healthcare delivery.
What's next for Clarium?
With the successful closure of its Series A round, Clarium is well-positioned to accelerate the deployment of Astra OS across a broader network of healthcare providers. The strategic involvement of industry-leading investors suggests a roadmap focused on deepening product capabilities and expanding market penetration. Future growth will likely center on enhancing the platform's predictive analytics and strengthening the integration between clinical demand and supply chain fulfillment. As the company matures, it is expected to leverage its strong institutional partnerships to set new standards for transparency and efficiency in the global healthcare supply chain, effectively transitioning from a high-growth startup to a foundational enterprise software provider.
See full Clarium company page
